Jon Sharp on the Future of Psychedelic Therapy and Drug Policy Reform
I think that we need to open up the doors- you know we don't need to keep it so tight- of who we're allowing to use these things, because I think so many people could benefit from them.
Picture a world where drug policies are based on science and compassion rather than fear and punishment. In this episode of 'The Peace on Drugs', Aaron Akulis sits down with Jon Sharp, Science and Communications Officer at The Beckley Foundation, to explore this vision. Jon shares his expertise on the hurdles faced in the UK regarding drug policy reform and sheds light on the promising benefits of psychedelic-assisted therapy.
From the nuances between LSD and psilocybin to the risks associated with synthetic cannabinoids and ketamine, this conversation covers it all. Jon passionately argues for opening up access to these therapies, especially for end-of-life patients and those struggling with mental health issues. He believes that many could benefit if the doors to psychedelic treatments were less restricted.
If you're curious about the future of drug policies or the potential of psychedelics in therapy, this episode offers a compelling and informative listen.